IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NQ Hcif GP, Ltd.

Q4 2014 Holdings

Filed 2015-02-17 | 1 holdings | $52.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revance Therapeutics, Inc.(RVNCEUR)COM761330109$52.5K3,096,650100.0%